Gut Health: Supplements That Work vs Popular Ones With No Evidence

Evidence summary

Supplement or claim	Evidence	Primary source	Funding / conflict trace	Verdict
Psyllium / soluble fiber for IBS symptoms.	ACG recommends soluble fiber, not insoluble fiber, for global IBS symptoms; older meta-analysis supports fiber as a class but psyllium is preferred over bran.	ACG IBS guideline; Ford et al., BMJ	ACG is a professional-society guideline; PubMed XML listed no grant or COI statement. BMJ review did not show supplement-company funding in fetched record.	WORKS
Enteric-coated peppermint oil for IBS pain/spasm.	Meta-analyses show benefit for global IBS symptoms and pain; one high-quality RCT had mixed primary vs secondary endpoint results.	2022 peppermint oil meta-analysis record; Weerts et al. RCT	PubMed XML listed no grants/conflicts for these records; product-specific formulations remain commercially relevant.	WORKS / MIXED
Bifidobacterium infantis 35624 for IBS.	Multicenter RCT in women with IBS found dose-specific benefit; strain-specific meta-analysis found inconsistent findings across trials.	Whorwell et al.; B. infantis 35624 meta-analysis	PubMed XML did not list grants/conflicts, but the strain is product-specific and commercially valuable; independence is therefore unclear.	SELECTED USE
Bifidobacterium bifidum MIMBb75 for IBS.	RCTs of viable and heat-inactivated MIMBb75 report IBS symptom improvement; WGO lists this strain with evidence level 2 for IBS.	Guglielmetti et al.; Andresen et al.; WGO guideline	PubMed XML did not list grants/conflicts for the records reviewed; strain-specific commercial relevance remains a downgrade.	SELECTED USE
Lactiplantibacillus plantarum 299v for IBS.	One RCT reported improvement in abdominal pain and bloating; another RCT found no significant abdominal pain relief difference, so the evidence is not uniform.	Ducrotté et al.; Stevenson et al./RCT record	PubMed XML listed no grants/conflicts for the records, but evidence remains strain- and product-specific.	MIXED
Saccharomyces boulardii for antibiotic-associated diarrhea prevention.	Systematic review with meta-analysis found reduced antibiotic-associated diarrhea risk; this is not the same as proving IBS benefit.	S. boulardii AAD meta-analysis	PubMed XML listed no grants/conflicts for the record; yeast-probiotic commercial relevance remains.	WORKS for selected indication
Prebiotics for IBS.	Meta-analyses show inconsistent effects; NCCIH notes lower-dose non-inulin fructans may help flatulence while inulin-type fructans can increase flatulence.	Wilson et al.; NCCIH IBS review	Wilson et al. listed Medical Research Council support in PubMed XML; NCCIH is a public-health source.	MIXED
Lactase for lactose intolerance.	Human enzyme replacement trials show improved lactose digestion and lower breath hydrogen after lactose exposure.	adult lactase deficiency trial; comparative lactase trial	Older PubMed XML records listed no grants/conflicts; evidence applies to lactose maldigestion, not all bloating.	WORKS
Alpha-galactosidase for gas.	Meal-challenge evidence supports reduced intestinal gas after bean challenge; IBS symptom trial evidence is mixed.	Di Stefano et al.; IBS alpha-galactosidase trial	PubMed XML listed no grants/conflicts for reviewed records; use only for food-specific gas claims.	INDICATION-SPECIFIC
Generic “digestive enzyme blends” for daily bloating.	Evidence is much stronger for diagnosed enzyme problems than for broad wellness blends.	digestive enzyme supplementation review; PERT review	Review evidence includes medical indications; broad supplement blends often lack independent testing.	INSUFFICIENT
Detox, juice cleanse, and colon cleanse claims.	NCCIH says detox evidence is low quality; colonic cleansing systematic review found no rigorous support for health promotion and reports adverse effects.	NCCIH detox/cleanse fact sheet; Acosta & Cash	NCCIH is a public-health source; Acosta & Cash has no apparent product upside from the PubMed record.	DOESN’T
Apple cider vinegar as a gut-health miracle.	Small studies address glycemia or delayed gastric emptying, not microbiome repair or IBS cure; injury case reports and product variability raise safety concerns.	gastroparesis pilot study; ACV tablet injury report	Clinical records do not establish a gut-health indication; commercial claims are usually marketing extrapolations.	DOESN’T for gut-health cure claims

Text version of this infographic

Choose gut supplements by symptom pattern. Hard stools or IBS-C points to psyllium; IBS pain or spasm may justify an enteric-coated peppermint oil trial; milk-triggered symptoms point to lactase or lactose testing; bean-triggered gas may justify alpha-galactosidase; antibiotic-associated diarrhea prevention may justify S. boulardii only when appropriate; red flags or malabsorption require medical evaluation first. Skip detoxes, colon cleanses, apple-cider-vinegar miracle shots, and generic leaky gut cure stacks.

The bottom-line ranking

All forms and grades

Category	Common forms	What it is	Best use	Verdict
Bulk-forming soluble fibers	Psyllium husk powder/capsules, ispaghula, partially hydrolyzed guar gum.	Water-holding fibers that change stool texture and fermentation patterns.	IBS-C, mixed stool patterns, constipation tendency.	Works best when titrated slowly.
Fermentable prebiotics	Inulin, FOS, GOS, resistant starch, acacia fiber.	Substrates intended to feed selected microbes.	Selected constipation or microbiome-feeding goals.	Mixed in IBS; gas risk is real.
Probiotics	Capsules, sachets, fermented milks, freeze-dried bacteria, probiotic yeast.	Live microorganisms intended to confer a health benefit at adequate amounts.	Named strain for named outcome.	Strain-specific; generic claims fail.
Synbiotics	Probiotic plus prebiotic combinations.	A live microbe paired with a substrate.	Occasionally studied for specific outcomes.	Do not assume combo is better.
Postbiotics / heat-killed microbes	Heat-inactivated strains, microbial metabolites, cell-wall preparations.	Non-living microbial preparations or metabolites.	Emerging; MIMBb75 heat-inactivated strain has IBS RCT evidence.	Promising but product-specific.
Botanical antispasmodics	Enteric-coated peppermint oil, peppermint blends, carminative teas.	Plant oils or herbs used for spasm/gas symptoms.	Enteric-coated peppermint oil for IBS pain/spasm.	Peppermint has evidence; blends vary.
Digestive enzymes	Lactase, alpha-galactosidase, pancreatic enzymes, broad blends with amylase/protease/lipase, papain/bromelain.	Enzymes that break specific nutrients into smaller molecules.	Specific enzyme gap or diagnosed disease.	Works only when matched to substrate/disease.
“Gut lining” formulas	L-glutamine, collagen, zinc carnosine, aloe, slippery elm, marshmallow root, butyrate salts.	Products marketed to “seal” or “repair” the intestinal barrier.	Research context or specific diagnoses, not generic cure claims.	Insufficient for leaky-gut cure marketing.
Acid/fermentation tonics	Apple cider vinegar shots/gummies, kombucha concentrates, bitters.	Acidic or fermented products sold for digestion or metabolism.	Food preference, not IBS or microbiome cure.	Overhyped; ACV has safety issues.
Cleanses	Juice cleanses, laxative teas, colon hydrotherapy, coffee enemas, detox kits.	Programs marketed to remove toxins or reset the bowel.	No routine gut-health role.	Doesn’t work and can harm.

What works

Psyllium: the most practical IBS fiber

Psyllium works because it holds water, forms a gel, and improves stool consistency without the same rapid fermentation burden as many prebiotic powders. ACG recommends soluble fiber but not insoluble fiber for global IBS symptoms, making psyllium a better first supplement than wheat bran for IBS-type symptoms (ACG guideline). Psyllium is not risk-free. Bulk-forming fibers can cause bloating and can obstruct the throat or bowel if taken dry or with too little fluid, so people with swallowing difficulty or suspected bowel narrowing need medical advice before use (psyllium adverse effects report, psyllium review).

Enteric-coated peppermint oil: useful for selected IBS pain

Peppermint oil is a smooth-muscle antispasmodic, and the active menthol-rich oil can reduce intestinal spasm in some IBS patients. A 2022 updated meta-analysis supports benefit, while a 2020 randomized trial found mixed results because primary endpoints were not significantly different even though some secondary pain and discomfort outcomes improved (peppermint meta-analysis, Weerts trial). The evidence applies mainly to enteric-coated products studied for IBS, not peppermint candy, essential oil drops, or peppermint tea. Peppermint oil commonly causes reflux-type symptoms, so people with GERD or hiatal hernia should be cautious (peppermint safety review).

Lactase: works when lactose is the problem

Lactase supplements help digest lactose, and older controlled human trials showed improved lactose digestion and reduced breath hydrogen after lactose-containing meals (adult lactase deficiency trial, comparative lactase trial). Lactase is a good example of an evidence-based enzyme because the enzyme, substrate, symptom trigger, and outcome all match.

Alpha-galactosidase: works best for a narrow food-gas problem

Alpha-galactosidase can reduce gas production from alpha-galactoside-rich foods such as beans in challenge settings, but IBS symptom trials are mixed (Di Stefano et al., IBS alpha-galactosidase trial). It is reasonable as a targeted meal tool, not as proof that chronic bloating is caused by a generalized enzyme deficiency.

Pancreatic enzymes: medical treatment, not wellness trend

Pancreatic enzyme replacement therapy is used for diagnosed exocrine pancreatic insufficiency, where fat maldigestion, weight loss, greasy stools, or pancreatic disease may be present. Evidence for PERT should not be transferred to over-the-counter enzyme blends for ordinary bloating (PERT review, digestive enzyme supplementation review).

Text version of this infographic

The evidence-versus-hype matrix places psyllium, lactase, and peppermint oil toward the higher-evidence side; specific probiotics and prebiotic powders in the mixed middle; and leaky-gut cure stacks, colon cleanses, and apple-cider-vinegar miracle claims in the high-hype, low-evidence area.

What is mixed or overhyped

Specific probiotics: possible, but not generic

A real probiotic claim must name the strain, dose, outcome, and population. NCCIH states that different probiotics can have different effects and that if one Lactobacillus helps prevent an illness, another Lactobacillus or Bifidobacterium cannot be assumed to do the same (NCCIH probiotics safety). For IBS, WGO lists B. bifidum MIMBb75 and L. plantarum 299v as strains with IBS evidence, and WGO’s older IBS guidance noted B. infantis 35624 as having one of the better IBS evidence bases, but ACG still recommends against routine probiotics for global IBS symptoms because the overall evidence is heterogeneous and low certainty (WGO probiotics/prebiotics guideline, WGO IBS guideline, ACG guideline).

Multi-strain probiotic hype

More strains and more CFU are not automatically better because strains can differ in survival, dose-response, metabolites, immune effects, and clinical endpoints. A probiotic label with 15 organisms but no matching RCT for the exact formula is weaker evidence than a modest single-strain product tested for the same condition.

Prebiotics: helpful substrate, not always IBS-friendly

Prebiotics can feed beneficial microbes, but IBS patients often react to fermentable carbohydrates. NCCIH reports that moderate amounts of some non-inulin-type fructans improved flatulence while inulin-type fructans increased flatulence in people with IBS, which is the opposite of most generic “feed your good bacteria” marketing (NCCIH IBS review).

Fermented foods and kombucha concentrates

Fermented foods are foods, not automatically probiotics. A review found limited clinical evidence for most fermented foods in gastrointestinal disease and noted that several popular fermented foods lacked RCT evidence for GI health at the time of review (Dimidi et al.). A 2024 kombucha clinical study was funded by GT’s Living Foods LLC and involved an author on its scientific advisory board, so it should not be treated as independent proof for kombucha supplement claims (kombucha clinical study).

Text version of this infographic

A probiotic label should provide: full identity with genus, species, and strain; dose or viable count through end of shelf life; outcome match such as IBS or antibiotic-associated diarrhea; and safety fit for the user. If the label cannot answer these four questions, the claim is marketing rather than evidence.

What does not work

Detox cleanses and juice cleanses

NCCIH states that detox and cleanse studies in people are few and low quality, and that some programs can be unsafe or falsely advertised (NCCIH detox/cleanse fact sheet). Juice cleanses can also expose susceptible people to high oxalate loads, unpasteurized-juice pathogens, low calorie intake, and delayed medical care for real digestive disease (NCCIH detox/cleanse fact sheet).

Colon cleanse and colon hydrotherapy

A systematic review in the American Journal of Gastroenterology found no methodologically rigorous controlled trials supporting colonic cleansing for general health promotion and noted multiple case reports and case series of adverse effects (Acosta & Cash). Colon cleansing is not a microbiome reset; it is a risk-containing procedure or laxative exposure without a wellness indication.

“Leaky gut supplement cures”

Intestinal permeability is a real research topic, but “leaky gut syndrome” cure marketing often jumps from mechanism to supplement stack without diagnostic criteria or outcome proof. A review on “leaky gut” ingredients declared no conflicts in PubMed XML, but it is still a narrative-style ingredient review and does not prove that consumer gut-lining stacks cure IBS, autoimmune disease, fatigue, or food intolerance (leaky gut ingredients review, leaky gut myths review).

Apple cider vinegar miracle claims

Apple cider vinegar has been studied more for glycemic response and gastric emptying than for IBS or microbiome restoration. In a small pilot study of people with type 1 diabetes and gastroparesis, apple cider vinegar delayed gastric emptying further, and a separate report described esophageal injury and large quality variation among apple cider vinegar tablets (gastroparesis pilot study, ACV tablet injury report).

Mechanisms: why some work and others do not

Effective gut supplements usually have a clear target. Psyllium changes stool water and viscosity; peppermint oil relaxes intestinal smooth muscle; lactase digests lactose; alpha-galactosidase digests specific bean oligosaccharides; and pancreatic enzymes replace missing pancreatic digestive activity. Weak gut supplements usually rely on vague claims. “Detox” rarely names the toxin, dose, test, endpoint, or excretion pathway; “leaky gut cure” rarely proves a diagnosed permeability abnormality and clinical improvement; and multi-strain probiotic hype often skips the exact strain-and-outcome evidence required by probiotic science.

Risks and all side effects

Ingredient / category	Common side effects	Rare but serious risks	At-risk populations	Independent source
Psyllium	Gas, bloating, abdominal fullness, cramping, stool changes.	Choking, esophageal obstruction, bowel obstruction, allergic reactions.	Swallowing disorders, bowel strictures, severe constipation/impaction, low fluid intake.	adverse effects report; psyllium review
Peppermint oil	Heartburn, reflux, peppermint burps, nausea, abdominal discomfort, anal burning.	Reflux worsening, gallbladder symptom concern, allergic reactions.	GERD, hiatal hernia, gallbladder disease, severe liver disease, children unless clinician-guided.	peppermint safety review
Probiotics including Lactobacillus, Bifidobacterium, and S. boulardii.	Gas, bloating, stool changes.	Bacteremia, fungemia, sepsis, and severe or fatal infection in vulnerable people.	Premature infants, severe immunosuppression, central venous catheter, critical illness, disrupted gut barrier.	NCCIH probiotics safety
Prebiotics: inulin, FOS, GOS, resistant starch.	Flatulence, bloating, abdominal pain, cramps, diarrhea.	Severe symptom flares or dehydration if diarrhea occurs.	IBS with severe bloating, suspected SIBO, strict low-FODMAP phase.	NCCIH IBS review
Lactase.	Generally minimal; symptoms can persist if dose is too low for lactose load.	Masking another diagnosis if symptoms are not truly lactose-related.	Milk allergy, unexplained weight loss, anemia, persistent diarrhea, children with growth issues.	lactase trial
Alpha-galactosidase.	Variable GI response, bloating changes, discomfort.	Unclear safety in complex carbohydrate-active diabetes treatment.	People using acarbose/miglitol or with diabetes requiring close post-meal glucose control.	gas-production trial; IBS trial
Pancreatic enzymes.	Nausea, abdominal cramps, constipation, diarrhea, mouth irritation if chewed.	High-dose disease-specific risks, including fibrosing colonopathy concern in cystic fibrosis contexts.	Pancreatic disease, cystic fibrosis, gout/hyperuricemia, bowel strictures.	PERT review
Apple cider vinegar shots/tablets/gummies.	Throat burning, reflux, nausea, tooth enamel erosion risk, delayed gastric emptying.	Esophageal injury, worsened gastroparesis, possible hypokalemia with excessive chronic intake.	GERD, gastroparesis, diabetes with delayed gastric emptying, tooth enamel problems, swallowing disorders.	gastroparesis pilot study; ACV tablet injury report
Detoxes, laxative cleanses, colon hydrotherapy.	Diarrhea, cramps, nausea, dizziness, dehydration.	Electrolyte disorders, infection, kidney injury, bowel perforation, burns/inflammation, delayed diagnosis.	Kidney disease, heart disease, GI disease, diabetes, pregnancy, older adults, immunocompromised people.	NCCIH; colonic cleansing review

All interactions

Ingredient	Interacts with	Mechanism / direction	Severity	Action
Psyllium	Levothyroxine, lithium, carbamazepine, digoxin, antidepressants, antidiabetics, mineral supplements.	Fiber can reduce or delay absorption; added fiber can alter post-meal glucose and stool transit.	Use with caution.	Separate from medicines and monitor glucose if diabetes therapy is being adjusted.
Peppermint oil	Antacids, PPIs, H2 blockers.	Premature dissolution of enteric coating or altered release may increase reflux/upper-GI irritation.	Use with caution.	Use enteric-coated products and stop if heartburn worsens.
Peppermint oil	Cyclosporine, transplant medicines, narrow-therapeutic-index drugs.	Potential metabolism/transport effects are uncertain but clinically important if drug margin is narrow.	Clinician-guided.	Do not self-combine with transplant or narrow-therapeutic-index medicines.
Probiotic bacteria	Antibiotics.	Antibiotics can kill susceptible probiotic bacteria and reduce intended viability.	Timing issue.	Separate dosing if a clinician recommends use.
S. boulardii	Antifungal medicines.	Antifungals may inactivate yeast probiotic; high-risk patients face fungemia concerns.	Use with caution / avoid high-risk self-use.	Avoid in severe immunosuppression or central-line patients unless specialist-directed.
Prebiotics	Low-FODMAP diet, laxatives, antidiarrheals, diabetes medicines.	Fermentation can worsen gas and confound elimination testing; stool frequency and glucose response may shift.	Use with caution.	Start low; avoid high-dose inulin during low-FODMAP elimination.
Lactase	Lactose-containing meals.	Desired effect: hydrolyzes lactose into absorbable sugars.	Low.	Use only with lactose exposure; persistent symptoms need evaluation.
Alpha-galactosidase	Acarbose or miglitol; diabetes regimens.	Carbohydrate digestion and post-meal glucose patterns may change.	Use with caution.	Ask prescribing clinician if using carbohydrate-active diabetes medication.
Pancreatic enzymes	Meal fat content, acid suppression plans, disease-specific medicines.	Effect depends on timing with meals and disease state; inappropriate use can obscure diagnosis.	Clinician-guided.	Use for diagnosed pancreatic insufficiency under medical supervision.
Apple cider vinegar	Insulin, sulfonylureas, GLP-1/GIP-related delayed gastric emptying contexts, diuretics, digoxin.	May delay gastric emptying and affect glucose timing; excessive intake may affect potassium, increasing digoxin/diuretic concerns.	Use with caution / avoid as supplement in gastroparesis.	Do not use ACV shots as gut treatment if gastroparesis, reflux, or diabetes medication timing is an issue.
Detox/laxative cleanses	Diuretics, ACE inhibitors, ARBs, SSRIs/SNRIs, antiepileptics, lithium, digoxin, anticoagulants.	Fluid loss and electrolyte shifts can alter drug levels or toxicity and raise arrhythmia, seizure, kidney, or bleeding risk.	Avoid for wellness.	Do not use for gut health; medical bowel prep should be clinician-directed.

Text version of this infographic

High-risk combinations include cleanses with heart or kidney drugs because of electrolyte shifts and dehydration; probiotics in severe immune-risk patients because of infection or fungemia concern; psyllium with critical medicines because of absorption changes; peppermint oil with reflux medicines because of early release or heartburn; apple cider vinegar with gastroparesis or diabetes therapy because of delayed gastric emptying; and prebiotics during low-FODMAP testing because they confound the symptom trial. If a medicine prevents rejection, clots, seizures, arrhythmia, pregnancy, infection, or glucose emergencies, do not add gut supplements casually.

Who should avoid these supplements

People with blood in stool, black stools, unexplained anemia, unintentional weight loss, fever, persistent vomiting, nighttime diarrhea, severe dehydration, trouble swallowing, progressive symptoms, or new major bowel changes should seek medical evaluation before using gut supplements. ACG supports targeted testing for celiac disease and inflammatory bowel disease in relevant IBS presentations rather than assuming all digestive symptoms are functional (ACG guideline). People who are immunocompromised, critically ill, premature infants, central-line patients, or recovering from major GI injury should avoid self-prescribed probiotics because NCCIH reports severe or fatal infections in premature infants and serious complications in people with underlying health problems (NCCIH probiotics safety). People with reflux, gastroparesis, swallowing problems, gallbladder disease, kidney disease, heart disease, or complex medication regimens should be especially cautious because peppermint oil, apple cider vinegar, psyllium, and cleanses can worsen symptoms or interact with treatment.

What works / does not verdict table

Claim	Verdict	Evidence	Key caveat
Psyllium improves IBS-C or mixed stool patterns.	WORKS	ACG recommends soluble fiber for global IBS symptoms (ACG guideline).	Needs fluid and medication separation.
Enteric-coated peppermint oil helps IBS pain/spasm.	WORKS / MIXED	Meta-analyses support benefit, while newer RCT data are mixed on primary endpoints (peppermint meta-analysis, Weerts trial).	Reflux-prone people may do worse.
B. infantis 35624 helps every IBS patient.	MIXED	One large RCT found dose-specific benefit, but meta-analysis describes inconsistent findings (Whorwell et al., meta-analysis).	Evidence cannot be generalized to other Bifidobacterium strains.
B. bifidum MIMBb75 has IBS trial support.	WORKS for selected use	Viable and heat-inactivated strain trials reported symptom improvement (Guglielmetti et al., Andresen et al.).	Still product-specific and not routine for all IBS.
L. plantarum 299v is proven for all IBS.	MIXED	One RCT was positive and another did not show significant abdominal pain relief (Ducrotté et al., 2014 RCT).	Trial length, population, and endpoints matter.
S. boulardii prevents antibiotic-associated diarrhea.	WORKS for selected users	Meta-analysis supports reduced antibiotic-associated diarrhea risk (S. boulardii meta-analysis).	Avoid self-use in immunocompromised or central-line patients.
Prebiotic powder improves IBS.	MIXED	Evidence varies by type and dose; inulin-type fructans can increase flatulence in IBS (NCCIH IBS review).	Start low and avoid during low-FODMAP elimination.
Lactase helps lactose intolerance.	WORKS	Controlled trials showed improved lactose digestion (lactase trial).	Only helps lactose-triggered symptoms.
Alpha-galactosidase helps all bloating.	MIXED	Bean challenge evidence is positive; IBS symptom evidence is mixed (gas trial, IBS trial).	Best as meal-specific support.
Digestive enzyme blends fix poor digestion.	INSUFFICIENT	Evidence is indication-specific for lactase or pancreatic enzymes, not broad wellness blends (digestive enzyme review).	Persistent symptoms need diagnosis.
Leaky-gut supplement stacks cure IBS or autoimmune symptoms.	INSUFFICIENT	Barrier function is real, but consumer cure claims exceed clinical evidence (leaky gut ingredients review, leaky gut myths review).	Do not use to replace diagnosis or treatment.
Colon cleanses reset the gut.	DOESN’T	No rigorous evidence supports colonic cleansing for general health promotion (Acosta & Cash).	Can cause serious adverse effects.
Apple cider vinegar cures digestion or microbiome problems.	DOESN’T	Evidence does not support IBS or microbiome cure claims; safety reports include delayed gastric emptying and esophageal injury (gastroparesis pilot, ACV injury report).	Especially risky in reflux or gastroparesis.

Independent evidence and money trail

Evidence source	Country / type	Funding and conflict check	Independence rating	Credibility rank	Used for
ACG IBS guideline	United States professional society guideline.	PubMed XML did not list grants or conflicts; professional-society authors may have separate disclosures in full guideline.	Probably independent.	Strong.	IBS fiber, peppermint, probiotic, low-FODMAP context.
NCCIH probiotics safety	United States public-health agency.	Public-health source with no product sales incentive.	Independent.	Very strong.	Probiotic safety and strain-specific warning language.
WGO probiotics/prebiotics guideline	Global professional guideline.	Useful global guideline, but probiotic-field expert panels can include industry-adjacent expertise; strain claims are therefore cross-checked against trials.	Probably independent for framework; cautious for product-specific strain tables.	Moderate–Strong.	Probiotic definition, strain specificity, selected IBS strains.
B. infantis 35624 RCT	Clinical trial.	PubMed XML did not list grants/conflicts; strain has clear commercial value.	Unclear.	Moderate.	Used only as strain-specific evidence.
B. bifidum MIMBb75 RCT	Clinical trial.	PubMed XML did not list grants/conflicts; strain-specific commercial relevance remains.	Unclear/probably product-relevant.	Moderate.	Used only for MIMBb75, not probiotic category claims.
Peppermint oil meta-analysis	Academic systematic review.	PubMed XML listed no grants/conflicts for the record.	Probably independent.	Strong.	Peppermint oil efficacy and safety.
Prebiotic meta-analysis	Academic systematic review.	Medical Research Council support listed in PubMed XML; no company funding seen in record.	Independent/probably independent.	Strong.	Prebiotic uncertainty.
NCCIH detox/cleanse fact sheet	United States public-health agency.	No product sales incentive; public safety mission.	Independent.	Very strong.	Detox, cleanse, juice, and colon-cleanse safety.
Kombucha controlled study	Clinical study.	Conflicted: funded by GT’s Living Foods LLC and one author served on the company scientific advisory board.	Conflicted.	Downgraded.	Example of why fermented supplement claims need funding checks.

Text version of this infographic

The money-trail rule: when a product owner funds a trial and one strain or formula shows benefit, marketing often leaps to “all probiotics work” or “all gut products work.” The editorial response is to cite the exact product or strain only, downgrade conflicts, and reject category-wide extrapolation.

Frequently asked questions

What gut supplement has the best evidence?

Psyllium has the best practical evidence for common IBS/constipation-type use because ACG recommends soluble fiber for global IBS symptoms. Lactase is also strong when lactose is the confirmed trigger, and peppermint oil is reasonable for selected adults with IBS pain or spasm (ACG guideline, lactase trial, peppermint meta-analysis).

Are multi-strain probiotics better?

Not automatically. NCCIH explains that different probiotic types can have different effects, so one strain’s benefit cannot be generalized to another strain or blend; a multi-strain label without exact formula evidence is usually weaker than a named strain studied for the same outcome (NCCIH probiotics safety).

Which probiotic strains have IBS evidence?

Human IBS trials exist for B. infantis 35624, B. bifidum MIMBb75, and L. plantarum 299v, but evidence is strain-specific and not uniformly positive. ACG still recommends against routine probiotic use for global IBS symptoms because the category evidence is heterogeneous and low certainty (Whorwell et al., Guglielmetti et al., Ducrotté et al., ACG guideline).

Do prebiotics help or hurt IBS?

Both are possible. NCCIH reports that some non-inulin-type fructans at moderate amounts improved flatulence, while inulin-type fructans increased flatulence in IBS, so prebiotic type and dose matter (NCCIH IBS review).

Do digestive enzyme blends work?

Digestive enzymes work when matched to a specific substrate or disease, such as lactase for lactose or pancreatic enzymes for pancreatic insufficiency. Broad blends marketed for everyday bloating have much weaker evidence and should not replace evaluation for persistent symptoms (lactase trial, PERT review).

Can apple cider vinegar improve gut health?

Apple cider vinegar is not an evidence-based IBS or microbiome treatment. It can delay gastric emptying and has been associated with esophageal injury in tablet form, so miracle digestion claims are not worth the risk for people with reflux, gastroparesis, or swallowing problems (gastroparesis pilot study, ACV tablet injury report).

Are colon cleanses good for gut health?

No. NCCIH warns that detoxes and cleanses can be unsafe, and a systematic review found no rigorous evidence supporting colonic cleansing for general health promotion (NCCIH detox/cleanse fact sheet, Acosta & Cash).

What is the safest way to test a gut supplement?

Test one evidence-matched supplement at a time, define the target symptom, use a short trial window, record stool pattern and pain/bloating changes, and stop if side effects occur. Do not self-test supplements when red flags, immunosuppression, central venous catheters, pregnancy complications, severe reflux, kidney disease, heart disease, or complex medicines are present.

Sources and publishing notes

1. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021.
2. Su GL, Ko CW, Bercik P, et al. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 2020.
3. World Gastroenterology Organisation. Probiotics and Prebiotics Global Guideline. 2023.
4. NCCIH. Probiotics: Usefulness and Safety.
5. NCCIH. Irritable Bowel Syndrome and Complementary Health Approaches.
6. Whorwell PJ, et al. Efficacy of Bifidobacterium infantis 35624 in women with IBS. Am J Gastroenterol. 2006.
7. Efficacy of Bifidobacterium infantis 35624 in IBS: meta-analysis. PubMed.
8. Guglielmetti S, et al. Bifidobacterium bifidum MIMBb75 in IBS. Aliment Pharmacol Ther. 2011.
9. Andresen V, et al. Heat-inactivated Bifidobacterium bifidum MIMBb75 in IBS. Lancet Gastroenterol Hepatol. 2020.
10. Ducrotté P, et al. Lactobacillus plantarum 299v in IBS. World J Gastroenterol. 2012.
11. Randomized clinical trial: Lactobacillus plantarum 299v on IBS symptoms. PubMed.
12. Systematic review with meta-analysis: Saccharomyces boulardii in antibiotic-associated diarrhea. PubMed.
13. Wilson B, Rossi M, Dimidi E, Whelan K. Prebiotics in IBS and functional bowel disorders. Am J Clin Nutr. 2019.
14. Systematic review and meta-analysis: efficacy of peppermint oil in IBS. PubMed.
15. Weerts ZZRM, et al. Efficacy and safety of peppermint oil in IBS. Gastroenterology. 2020.
16. Review article: physiologic effects and safety of peppermint oil. PMC.
17. Enzyme replacement therapy for primary adult lactase deficiency. PubMed.
18. Comparative effects of exogenous lactase preparations on lactose digestion. PubMed.
19. Di Stefano M, et al. Oral alpha-galactosidase and intestinal gas production. PubMed.
20. Does oral alpha-galactosidase relieve irritable bowel symptoms? PubMed.
21. Digestive enzyme supplementation in gastrointestinal diseases. PMC.
22. Pancreatic exocrine insufficiency: diagnostic evaluation and pancreatic enzyme replacement therapy. PubMed.
23. NCCIH. “Detoxes” and “Cleanses”: What You Need To Know.
24. Acosta RD, Cash BD. Clinical effects of colonic cleansing for general health promotion. Am J Gastroenterol. 2009.
25. Effect of apple cider vinegar on delayed gastric emptying in type 1 diabetes mellitus: pilot study. PubMed.
26. Esophageal injury by apple cider vinegar tablets and product evaluation. PubMed.
27. Leaky Gut and the Ingredients That Help Treat It: A Review. PubMed.
28. Leaky Gut Syndrome: Myths and Management. PMC.